Survey 16 – Perspectives on Cough Expectorants in Bronchitis Management

Survey 16 - Perspectives on Cough Expectorants in Bronchitis Management

MCI Registration Number

First Name

Last Name

Phone/Mobile

City

State

Speciality

Bank Details

Upload Cancelled Cheque (Max Size 2MB)

Choose File

Upload Pancard Details (Max Size 2MB)

Choose File

Questionnaire: Perception Mapping Study Questionnaire: Consulting Physicians’ Perspectives on Cough Expectorants in Bronchitis Management

Section 1: Prescribing Habits & Product Selection

1. What factors most influence your choice of cough expectorants for bronchitis?

Efficacy in mucus clearance

Safety profile (e.g., minimal side effects)

Patient compliance (e.g., taste, dosing frequency)

Cost/insurance coverage

2. How often do you prescribe combination expectorants (e.g., Ambroxol + Levosalbutamol + Guaiphenesin)?

Very frequently (>70% of cases)

Occasionally (30–70% of cases)

Rarely (<30% of cases)

Never

3. Which bronchodilator do you prefer in cough syrups for bronchitis?

Levosalbutamol

Terbutaline

No preference

Other (specify)

Others (specify)

4. How important is rapid bronchodilation in selecting a cough syrup?

Extremely important

Moderately important

Slightly important

Not important

Section 2: Side Effects & Safety Perceptions

5. How often do you observe side effects (e.g., tremors, palpitations) with terbutalinecontaining expectorants?

Frequently (>30% of patients)

Occasionally (10–30% of patients)

Rarely (<10% of patients)

Never

6. Which terbutaline-related side effect is most commonly reported by patients?

Tremors/shaking

Sleepiness/drowsiness

Weakness/fatigue

Palpitations

7. Does the safety profile of levosalbutamol influence your preference over terbutaline?

Strongly influences

Moderately influences

Slightly influences

No influence

8. How significant is the risk of tolerance with long-term terbutaline use?

Very significant

Moderately significant

Slightly significant

Not significant

Section 3: Role of Levosalbutamol vs. Terbutaline

9. In your experience, which bronchodilator provides better symptom relief in bronchitis?

Levosalbutamol

Terbutaline

Both are similar

Not sure

10. How would you rate the cardiovascular safety of levosalbutamol compared to terbutaline?

Much safer

Slightly safer

Equally safe

Less safe

Section 4: Flavour & Patient Compliance

11. How important is flavour in ensuring patient compliance with cough syrups?

Extremely important

Moderately important

Slightly important

Not important

12. Which flavour do you believe patients prefer most?

Peppermint

Fruit (e.g., orange, strawberry)

Honey

Neutral/no preference

13. Do you adjust prescriptions based on a patient’s flavour preference?

Always

Often

Occasionally

Never

Section 5: Patient Demographics & Profiles

14. Which age group most commonly requires cough expectorants for bronchitis?

<18 years

18–40 years

41–60 years

>60 years

15. What comorbidities are most associated with your bronchitis patients?

Asthma/COPD

Diabetes

Hypertension

None

16. How often do you encounter patients with poor tolerance to bitter-tasting syrups?

Very frequently

Occasionally

Rarely

Never

Section 6: Compliance & Follow-Up

17. What percentage of your patients adhere to prescribed cough syrup regimens?

>75%

50–75%

25–50%

<25%

18. Which factor most impacts patient compliance?

Side effects

Taste/texture

Dosing frequency

Symptom relief speed

19. How do you typically address non-compliance?

Switch formulations (e.g., tablets to syrup)

Educate on benefits

Adjust flavour/dosing

Prescribe alternative drugs

I have read and agree to the Terms and Conditions .